Login / Signup

The utility of PRAME staining in identifying malignant transformation of melanocytic nevi.

Mary E LohmanAaron J SteenRoy C GrekinJeffrey P North
Published in: Journal of cutaneous pathology (2021)
We identified a high rate (67%) of differential PRAME staining in adjacent benign and malignant melanocyte populations in NAM. In PRAME positive (4+) melanomas, PRAME differentiates 100% (24/24) of benign and malignant melanocyte populations. When 4+ staining is used as the threshold for positivity, PRAME staining has a sensitivity of 67% (24/36) and a specificity of 100% (36/36). These results support PRAME IHC can assist in distinguishing melanocyte populations in melanoma arising within nevi.
Keyphrases
  • flow cytometry
  • genetic diversity
  • skin cancer